Abstract:This presentation aims to provide an overview of the manifestations of some unusual benign focal liver lesions (FLLs) on low-acoustic power contrast-enhanced sonography (CES) with a sulfur hexafluoride contrast agent.The patients were selected retrospectively from 2209 cases with FLLs who had undergone CES examinations for characterization during the past 3 years. The pathologic examinations proved that they were intrahepatic biliary cystadenoma (n = 1), angiomyolipoma (AML; n = 4), lipoma (n = 1), biliary epithelial dysplasia (n = 1), a fungal inflammatory mass (n = 1), tuberculoma (n = 2), an inflammatory pseudotumor (n = 7), sarcoidosis (n = 1), solitary necrotic nodules (n = 2), peliosis hepatis (n = 2), and focal fibrosis after surgery (n = 4).Contrast-enhanced sonography was beneficial in leading to a diagnosis of benignity for some lesions showing hyperenhancement during the arterial phase and sustained enhancement during the portal or late phase, such as liver AML and lipoma. The benign nature of other lesions showing no enhancement during all phases, such as solitary necrotic nodules and focal fibrosis, was also suggestible. On the other hand, for those lesions showing hyperenhancement, isoenhancement, or hypoenhancement during the arterial phase and hypoenhancement during the late phase, including intrahepatic biliary cystadenoma, biliary epithelial dysplasia, infected liver diseases, the inflammatory pseudotumor, sarcoidosis, and peliosis hepatis, the differential diagnosis between benignity and malignancy was difficult, and pathologic tests were mandatory.The CES features of unusual benign FLLs may enrich knowledge when performing CES examinations for characterization and may provide clues for a specific diagnosis of an individual lesion such as liver AML.

Comments and illustrations of the WFUMB CEUS liver guidelines: rare benign hematological focal liver lesions (hepatic extramedullary hematopoiesis, Hemophagocytic lymphohistiocytosis, reactive lymphoid hyperplasia)

Comments and Illustrations of the WFUMB CEUS Liver Guidelines: Rare Focal Liver Lesions - Infectious (Bacterial).

Comments and Illustrations of the WFUMB CEUS Liver Guidelines: Rare Malignant Hematological Liver Lesions.

Comments and illustrations of the WFUMB CEUS liver guidelines: Rare focal liver lesions - non-infectious, non-neoplastic

Comments and illustrations of the WFUMB CEUS liver guidelines: Rare benign focal liver lesion, part I

Comments and Illustrations of the WFUMB CEUS Liver Guidelines: Rare Benign Focal Liver Lesion, Part II.

Comments on and illustrations of the WFUMB CEUS liver guidelines: Rare malignant neuroendocrine and predominant epithelioid liver lesions

Comments on and illustrations of the WFUMB CEUS liver guidelines: Rare malignant mesenchymal liver lesions

Comments and illustrations of the WFUMB CEUS liver guidelines: Rare focal liver lesion - infectious parasitic, fungus

Comments and Illustrations of the WFUMB CEUS Liver Guidelines: Peliosis Hepatis and Porphyria

Comments and Illustrations of the WFUMB CEUS Liver Guidelines: Cystic Fibrosis Associated Liver Disease

Liver Tumor Characterization – Comments and Illustrations Regarding Guidelines

Effectiveness of Application of CEUS in Diagnosis of Focal Liver Lesions

Characterization of Focal Liver Lesions Indistinctive on B Mode Ultrasound: Benefits of Contrast-Enhanced Ultrasound

Undetermined Focal Liver Lesions on Gray-Scale Ultrasound in Patients with Fatty Liver: Characterization with Contrast-Enhanced Ultrasound

Contrast enhanced ultrasound (CEUS) imaging of solid benign focal liver lesions.

Contrast-enhanced Ultrasound of Histologically Proven Hepatic Epithelioid Hemangioendothelioma.

0511: Focal Hypoechoic Tumors in Fatty Liver: Characterization of Conventional and Contrast-Enhanced Sonography

Real-time Contrast Enhanced Ultrasound Imaging of Focal Splenic Lesions

Unusual Benign Focal Liver Lesions

Three Cases of Hepatic Epithelioid Hemangioendothelioma Evaluated Using Conventional and Contrast-Enhanced Ultrasound: Case Reports.